Bals-PratschM, LongerK., PlaceV.A., NieschlagE.: Substitution therapy of ipogonadal men with transdermal testosterone over one year. Acta Endocrinol, 118; 7 (1988).
2.
BareyB.W.: Mode of action of penetration enhancers in human skin. J. Controlled Release, 6; 85 (1987).
3.
BrindleyGS.: Cavernosal alpha blockade: A new technique for investigating and treating erectile impotence. Brit. J. Psychiat., 143; 332 (1983).
4.
ChetkowskiR.J., MeldrumR.J., SteingolK.A.: Biologic effects of transdermal estradiol. N. Engl. J. Med., 314; 1615 (1986).
5.
GlassM., StephenR., JacobsenS.: The quantity and distribution of radiolabeled dexamethasone delivered to tissues by iontophoresis. Intern. J. Derm., 19; 519 (1980).
6.
JungG., KatzE., SchmittH., VogesK., MenestrinaG., BoheimB.: Conformational and requirements for the potential dependent pore formation of the peptide antibiotics alamethicin, suzukacillin and trichoto-xin. Physical Chemistery of Transmembrane Ion Motion, 1983.
7.
LarsenE.H., GasserT.C., BruskewitzR.C.: Fibrosis of corpus cavernosum after intracarnous injection of phentolamine/papaverine. J. Urol., 137; 292 (1987).
8.
MenchiniFabris G.F., GiorgiP.M., Di CoscioM., CanaleD.: Epidemiology of male sexual impotence. In: Diagnosing Impotence, PozzaD., ColpiG.M. (edrs.) Masson, Roma 1990.
9.
PikalM.J.: Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res., 7; 118 (1990).
10.
RobinetteM.A., MoffatM.J.: Intracorporal injection of papaverine and phentolamine in the management of impotence. Brit., J. Urol., 58; 692 (1986).
11.
VoragR.: Intracavernous injection of papaverine for erectile failure. Lancet, 2; 938 (1982).
12.
ViragR.: About pharmacologically induced prolonged erection. Lancet, 1; 518 (1985).